J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sriramulu, D. D
Right arrow Articles by Römling, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sriramulu, D. D
Right arrow Articles by Römling, U.
Agricola
Right arrow Articles by Sriramulu, D. D
Right arrow Articles by Römling, U.
J Med Microbiol 54 (2005), 667-676; DOI: 10.1099/jmm.0.45969-0
© 2005 Society for General Microbiology
ISSN 0022-2615

Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung

Dinesh D Sriramulu1,2, Heinrich Lünsdorf3, Joseph S Lam4 and Ute Römling1

1Microbiology and Tumor Biology Center (MTC), Karolinska Institutet, 17177 Stockholm, Sweden 2,3Department of Cell Biology and Immunology2 and Department of Microbiology3, Gesellschaft für Biotechnologische Forschung, 38124 Braunschweig, Germany 4Department of Microbiology, University of Guelph, Canada N1G2W1

Correspondence Ute Römling Ute.Romling{at}mtc.ki.se

Received November 25, 2004
Accepted March 11, 2005

Pseudomonas aeruginosa colonizing the lung of cystic fibrosis patients is responsible for a decline in health and poor prognosis for these patients. Once established, growth of P. aeruginosa in microcolonies makes it very difficult to eradicate the organisms by antimicrobial treatment. An artificial sputum medium was developed to mimic growth of P. aeruginosa in the cystic fibrosis lung habitat and it was found that the organisms grew in tight microcolonies attached to sputum components. Several genes, such as algD, oprF and lasR but not fliC, were required for tight microcolony formation. Among the sputum components, amino acids, lecithin, DNA, salt and low iron were required for tight microcolony formation. Amino acids were also shown to be responsible for various other cystic-fibrosis-specific phenotypes of P. aeruginosa, such as diversification of colony morphology, alterations in LPS structure and hyperexpression of OprF. Since the amino acid content of sputum is elevated in severe lung disease, it is suggested that the tight microcolony biofilm is maintained in these conditions and that they contribute to the vicious cycle of disease severity and failure to eradicate the organism. Thus, growth of P. aeruginosa in artificial sputum medium is an appropriate model of chronic lung colonization and may be useful for evaluating therapeutic procedures and studying antibiotic-resistance mechanisms.


Abbreviations: ASM+, basic artificial sputum medium; ASM-, artificial sputum medium without amino acids; CF, cystic fibrosis.


    INTRODUCTION
 TOP
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
Cystic fibrosis (CF), an autosomal inherited disease of Caucasians (Gibson et al., 2003), is caused by dysfunction of the CF transmembrane conductance regulator (CFTR). This disease predisposes patients to a broad spectrum of disease phenotypes including failure of lung function, which is the major cause of mortality among these patients. A limited spectrum of micro-organisms can colonize the CF lung, and Pseudomonas aeruginosa in particular is most associated with lung deterioration and a decline in health. Once established, P. aeruginosa is often refractory to antibiotic treatment, although high concentrations of some agents such as tobramycin can be achieved in the lung by inhalation (Ramsey et al., 1999). This persistence in the presence of antimicrobial agents is considered to be largely due to a biofilm mode of growth (Lam et al., 1980; Singh et al., 2000), whereby P. aeruginosa grows in microcolonies surrounded by an extracellular matrix of the exopolysaccharide alginate. Besides alginate overproduction, P. aeruginosa shows other diverse phenotypes, such as colony variation, loss of motility and type IV piliation, various modifications of the LPS and increased auxotrophy (Barth & Pitt, 1996; Ernst et al., 1999; Hancock et al., 1983; Mahenthiralingam et al., 1994).

The CF lung environment is characterized by the production of copious amounts of sputum, which covers the surface of the epithelial cells and impairs mechanical clearance mechanisms (Gibson et al., 2003). Although such a situation is not unique to CF, individuals with this disease harbour high numbers of bacteria in bronchopulmonary plugs that are unevenly distributed through the lung tissue (Baltimore et al., 1989; Worlitzsch et al., 2002). Bacterial colonization is probably promoted by the unique composition of the sputum, which contains mucin, lipids, proteins, amino acids, ions and DNA released by neutrophils in concentrations above the mean of a healthy individual (Barth & Pitt, 1996; Kilbourn, 1978; Sahu & Lynn 1978; Smith et al., 1988). Indeed, a number of studies have provided evidence for a correlation between individual sputum components and the emergence or stabilization of certain P. aeruginosa phenotypes (Govan, 1975; Ohman & Chakrabarty, 1982; Wang et al., 1996; Yoon et al., 2002).

Current conventional biofilm models observe cells attached to a solid biotic or abiotic surface in steady-state culture or under continuous flow (Christensen et al., 1999; Boddicker et al., 2002). However, P. aeruginosa grows in the CF lung under anaerobic conditions as microcolonies, a biofilm in which bacteria adhere to each other and to sputum components, but not to a surface (Lam et al., 1980; Baltimore et al., 1989; Worlitzsch et al., 2002). Recently, an anaerobic biofilm model was developed in which the bacteria overexpress the outer-membrane protein OprF, a feature that could be correlated with the in situ situation (Yoon et al., 2002). Neither this nor other models could demonstrate the ability of flagella negative strains to form biofilms (O'Toole & Kolter, 1998), but P. aeruginosa isolates from CF patients are frequently non-motile (Mahenthiralingam et al., 1994).

We have developed an artificial sputum medium with a composition that closely resembles CF sputum. In this medium, P. aeruginosa grows in microcolonies, thus presenting a novel model for biofilm formation in the CF lung. Various features of CF isolates, among others, flagella-independent microcolony formation, were displayed by P. aeruginosa grown in the artificial sputum medium.


    METHODS
 TOP
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
Bacterial strains and plasmids.

Bacterial strains and plasmids used in this study are listed in Table 1. Besides FRD1, all isolates were non-mucoid. P. aeruginosa PAO1C (ATCC15692) was purchased from the American Type Culture Collection (ATCC).


View this table:
[in this window]
[in a new window]
 
Table 1. Strains and plasmids
 

Artificial sputum medium and growth conditions.

The basic artificial sputum medium (ASM+) was 5 g mucin from pig stomach mucosa (NBS Biologicals), 4 g DNA (Fluka), 5.9 mg diethylene triamine pentaacetic acid (DTPA) (Sigma), 5 g NaCl, 2.2 g KCl, 5 ml egg yolk emulsion (phosphatidylcholine as source of lecithin) (Oxoid) and 5 g amino acids per 1 l water (pH 7.0) modified after Ghani & Soothill (1997). The same medium without amino acids was designated ASM–. For a standard experiment, an inoculum equivalent to OD600 0.05 of an overnight culture of P. aeruginosa PAO1C grown in tryptone soy broth (TSB) was added to 1 ml of sputum medium in 24-well cell-culture plates and incubated for 16 h at 37 °C with gentle shaking. To determine the growth rate, viable counts were performed with cultures grown for 6 h. Cells were treated for 30 min with cellulase (1 mg cellulase ml–1, 400 µg chloramphenicol ml–1 in 0.05 M citrate buffer, pH 4.6) to dissolve the clumps and plated on agar medium. Reconstituted sputum extracts (see below) were also used as growth media and the uninoculated sputum extract was used as a control. Viable and dead bacteria were discriminated using the LIVE/DEAD BacLight Bacteria Viability Kit (Molecular Probes) according to the instructions of the manufacturer. This kit is based on the membrane-permeant SYTO 9 dye, which labels live bacteria with green fluorescence, and propidium iodide, which labels membrane-compromised (non-viable) bacteria with red fluorescence.

Adherence to surface.

Adherence of P. aeruginosa to polystyrene wells was investigated by crystal violet staining in 24-well plates as described previously (Römling et al., 1998).

Assessment of phenotypic diversity.

For long-term incubation up to 45 days, standing cultures were set up in a conical flask 60 % filled with relevant medium. These were subcultured daily up to day 15, and at day 30 and day 45. Approximately 1000 colonies were examined for changes in colony morphology after overnight growth on tryptone soy agar (TSA) plates.

Transposon mutagenesis.

Transposon mutants were created by introduction of the Tn5-transposon-based transposome using EZ : : TN <KAN-2> Tnp transposome (Epicentre) into P. aeruginosa PAO1C by electroporation (2.0 kV, 25 µF, 200 {Omega}). P. aeruginosa transformants were selected for kanamycin resistance, restreaked, transferred to 96-well plates containing ASM+ and incubated overnight at 37 °C with shaking. Genomic DNA was isolated from appropriate mutants using the NucleoSpin Tissue kit (Macherey-Nagel), digested with PstI and ligated under conditions favouring intramolecular ligation. Insertion points of the kanamycin-resistance cassette were identified by sequencing of the fragment obtained by inverse PCR using primers provided by the manufacturer.

Preparation of sputum extracts.

Sputum extracts were prepared by adding an equal volume of sterile double-distilled water to the sputum. After centrifugation for 10 min at 14 000 g, the supernatant was passed through a 0.45 µm membrane filter (Millipore) and the pellet was saved. The filtrate was subsequently used for amino acid analysis or as bacterial growth medium when reconstituted with 20 µl of the resuspended pellet.

Quantification of free amino acids in sputum.

Free amino acids in the sputum extracts were quantitatively derivatized at the amino group, either primary or secondary, using phenylisothiocyanate (PITC) in the presence of a base, diisopropylethylamine (DIEA) (Applied Biosystems 420A Derivatizer). The derivatives, phenylthiocarbamyl-amino acids (PTC-aa) were analysed by HPLC (Applied Biosystems 130A Separation system) and quantified by comparison to standard concentrations of corresponding amino acids.

Analysis of LPS.

LPS from P. aeruginosa was isolated as described elsewhere (Hitchcock & Brown, 1983) and preparations were analysed by SDS-PAGE using 15 % discontinuous gels (Tsai & Frasch, 1982). Low-molecular-mass core-lipid A bands were resolved in 16.5 % Tricine SDS-PAGE gels (Lesse et al., 1990). For Western blot analysis, LPS bands from conventional and Tricine SDS-PAGE were transferred to polyvinylidenefluoride membranes (Millipore) and blocked with 5 % skimmed milk. The blotted membrane was incubated with mAbs 177, 7-4, 101 and N1F10 specific for lipid A, inner core, outer core and A-band (common conserved antigen), respectively (de Kievit & Lam, 1994), and a polyclonal antibody against the B-band (the variable O-antigen with O-chain repeating units). The blots were developed at room temperature with goat anti-mouse F(ab')2 conjugated antibody and detected using Lumilight (Roche).

Proteome analysis.

Whole-cell proteins were extracted, isoelectrically focussed in a linear pH range 4–7 in the first dimension and mass-separated in a 12–15 % gradient polyacrylamide gel in the second dimension (Gorg et al., 2000). The most prominent spot was identified as OprF. Tryptic digest of the eluted protein was performed and analysed by matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF), where eight of 19 peptides matched. Sequence analysis of peptides was done by MS/MS using Micromass Q-Tof-2 (Micromass) and the peptide sequences DVLVNEYGVEGGR and [Q]YPSTSTTVEGHTD[SV]GTD supported identification of OprF.

Electron microscopy.

Bacteria in microcolonies were fixed, embedded and ultrathin sectioned (Yakimov et al., 1998). Samples for scanning electron microscopy were prepared as described previously (Lünsdorf et al., 2001).


    RESULTS
 TOP
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
Microcolony formation of P. aeruginosa PAO1C in artificial sputum medium

To study biofilm formation of P. aeruginosa under conditions that closely resemble the CF lung habitat, we developed an artificial sputum medium (ASM+) that contained components such as mucin, DNA, surfactant, salt ions, iron and amino acids in concentrations found in an average sputum of a patient with CF (Ghani & Soothill, 1997). When P. aeruginosa PAO1C was grown in this medium, the cells formed macroscopically visible clumps (microcolonies), which could not be disrupted even by vigorous pipetting (Fig. 1). Light microscopy verified the formation of tight microcolonies with almost no planktonic cells. Staining of the well by crystal violet showed that the bacterial cells did not attach to a polystyrene and glass surface (Fig. 1, data not shown). The microcolonies formed by growth in ASM+ were termed ‘tight’ and those in ASM– were ‘loose'.



View larger version (108K):
[in this window]
[in a new window]
 
Fig. 1. Microcolony formation of P. aeruginosa PAO1C in ASM+ and ASM–. I, intact microcolonies in wells (below, corresponding phase-contrast microscopy images of cell mass, magnification, x1000); D, mechanical disruption of microcolonies by pipetting; CV, ‘conventional’ biofilm formation on the polystyrene surface visualized by crystal violet staining.

 

A similar pattern of growth in ASM+ was observed for one CF clinical isolate and three environmental isolates of P. aeruginosa. Each of the isolates grew in the loose microcolony mode in ASM–.

To investigate the components in the ASM+ that influenced the formation of tight microcolonies, P. aeruginosa PAO1C was grown in artificial sputum medium with individual components omitted stepwise (Fig. 2a). When amino acids were not available, the visible microcolony appeared smaller due to the increased number of planktonic cells (Fig. 1). The cells were easily disrupted by pipetting, confirming that they were only loosely connected, and light microscopy showed the bacterial cells to be associated loosely with each other in a background of planktonic cells (Fig. 1).



View larger version (104K):
[in this window]
[in a new window]
 
Fig. 2. (a) Effect of the different components in the artificial sputum medium on tight microcolony formation of P. aeruginosa PAO1C. P. aeruginosa PAO1C grown in (1) ASM+ and in the absence of (2) amino acid, (3) iron chelator, (4) DNA, (5) lecithin source, (6) mucin and (7) salts. (b) Effect of the concentration of amino acids on tight microcolony formation. (c) Correlation of amino acid content and microcolony formation of P. aeruginosa PAO1C in sputum extracts (Sp1–6) from CF patients. (d) Effect of individual amino acids (single letter code) on microcolony formation (left) and wall attachment (right) of P. aeruginosa PAO1C.

 

In the absence of mucin there was little growth, suggesting that mucin is a major energy source for P. aeruginosa in this medium. The lack of mucin also caused significant adherence of P. aeruginosa PAO1C to the walls of the polystyrene well, with the formation of a conventional biofilm. Lecithin, DNA, the salt components and a low iron content were required to a variable extent for the formation of tight microcolonies (Fig. 2a). In addition, we observed that a change in the surface area to volume ratio from 2 to 3.3 influenced tight microcolony formation (data not shown), suggesting a role for oxygen in the aggregative behaviour of the bacteria (Worlitzsch et al., 2002). In conclusion, all the components in the artificial sputum medium contributed to tight microcolony formation of P. aeruginosa PAO1C (Figs 1 and 2).

A dose-dependent correlation between amino acid content and tight microcolony formation was observed (Fig. 2b). Tight microcolonies began to be formed in approximately 0.5 mg amino acids ml–1. This observation likely reflects the situation of bacteria–host interactions in vivo, since tight microcolony formation of P. aeruginosa PAO1C was found to correlate with the amount of amino acids in sputum extracts from CF patients (Fig. 2c).

Individual amino acids had complex effects on growth and the degree of tight microcolony formation in the artificial sputum medium (Fig. 2d). Tryptophan was found to be required for tight microcolony formation; however, bacterial growth was restricted when tryptophan was used alone as the amino acid supplement.

Genes involved in P. aeruginosa microcolony formation in ASM+

To determine which gene products contribute to tight microcolony formation, selected genes previously reported to be required for conventional biofilm formation were investigated (Fig. 3). First, strains deficient in the production of structural components, such as extracellular polysaccharide alginate (algD) mutant, type IV pili (pilB) mutant and the flagellum (fliC) mutant, were compared with their respective isogenic wild-type strains (Table 1, Fig. 3 and data not shown). While alginate and pili affected tight microcolony formation, the lack of the flagellum had no effect. Since there is currently a debate about whether alginate production is required for conventional biofilm formation (Wozniak et al., 2003), we tested another algD mutant in a different strain background [FRD1 and FRD875 (algD : : xylE)], with essentially the same results (data not shown).



View larger version (82K):
[in this window]
[in a new window]
 
Fig. 3. Microcolony formation by P. aeruginosa PAO wild-type strains and mutants. Top row in each panel shows microcolony formation and bottom row shows bacterial aggregates after mechanical disruption. Strains: (a) PAO1, PAO6862 (PAO1 algD : : Gm); (b) PAO1 lecA : : lux, PAO1 lecA : : lux {Delta}lasR, PAO1 lecA : : lux {Delta}rhlR; (c) PAO1C (ATCC15962), PAO1C oprF : : <KAN-2>, PAO1C sucC : : <KAN-2>, PAO1C rmlA : : <KAN-2>.

 

Quorum sensing signals play a role in the development of biofilm architecture and their absence leads to less-severe chronic infections in mice (Wu et al., 2001). Therefore, lasR (senses the quorum sensing signal molecule 3O-C12-HSL) and rhlR (senses C4-HSL) mutants and their respective wild-type strains were tested. While lasR was required for tight microcolony formation, the rhlR mutant behaved similarly to the wild-type (Fig. 3).

To find novel genes, a panel of 270 transposon mutants were screened for the loss of tight microcolony formation. Transposon insertions were identified in oprF, rmlA and sucC (Table 1).

CF-specific phenotypes of P. aeruginosa grown in artificial sputum medium

We tested whether cultivation of P. aeruginosa in artificial sputum medium with (ASM+) and without (ASM–) amino acids resembles growth in the CF lung. P. aeruginosa PAO1C grew slowly in both media, with generation times of 2.3 h (ASM+) and 3.4 h (ASM–). After 16 h of growth, few dead cells were detected in ASM–, but a significant number of cells were not viable in ASM+. Such a slow growth rate and nonviable cells might reflect the situation in the lung. Otherwise the high number of bacterial cells that are reached in the lung would probably be fatal for the patient. Scanning and transmission electron microscopy showed an abundance of extracellular matrices around the cells in ASM+ medium and in a sputum extract, but these structures were rare around cells grown in ASM– (Fig. 4).



View larger version (127K):
[in this window]
[in a new window]
 
Fig. 4. Electron microscopy of P. aeruginosa PAO1C microcolonies. (a) Scanning electron micrographs of P. aeruginosa PAO1C microcolonies established in (1) ASM+, (2) ASM– and (3) sputum extract 5. (b) Transmission electron micrographs of P. aeruginosa PAO1C microcolonies established in (1) ASM+ and (2) ASM–. Bars: (a) 2 µm, (b) 1 µm.

 

In vitro diversification of P. aeruginosa colony morphology

A unique characteristic of P. aeruginosa growing in the CF lung is phenotypic diversification. To test the effect of the growth medium on colonial variation, P. aeruginosa PAO1C was incubated in TSB, ASM+ and ASM– up to 45 days. After 45 days no change in colony morphology was observed on subculture from TSB or ASM– (Fig. 5). However, cells grown in ASM+ yielded mucoid colonies after only 1 day. After 7 days of growth in ASM+, colony variation occurred in approximately 5–10 % of colonies. After 45 days, the majority of the colonies were dwarf or mucoid, but mucoidy was unstable and lost on subculture. Rough colonies and small-colony variants were other morphologies that closely resembled forms frequently isolated from CF patients.



View larger version (40K):
[in this window]
[in a new window]
 
Fig. 5. Morphological changes after long-term cultivation of P. aeruginosa PAO1C in (1) ASM+, (2) ASM– and (3) TSB for 45 days. Arrows: black, dwarf morphotype; dark grey, brown-pigmented morphotype; light grey, mucoid colony.

 

Modification of LPS in artificial sputum medium

The LPS is also subject to adaptive mutations in the CF lung habitat (Ernst et al., 1999). Following growth of P. aeruginosa PAO1C in ASM+ and ASM–, lipid A modification became apparent as lipid A was not detectable with the lipid A-specific mAb 177 (Fig. 6). A similar observation was made when P. aeruginosa PAO1C was grown in one of the sputum extracts (Fig. 6a). A low abundance of A-band antigen, the common antigen, was observed in ASM+ as well as when P. aeruginosa PAO1C was grown in the sputum extracts. Core-plus-one O-antigen repeat (core +1) was overexpressed when PAO1C was grown in ASM with and without amino acids as well as in one of the sputum extracts.



View larger version (31K):
[in this window]
[in a new window]
 
Fig. 6. LPS profile of P. aeruginosa PAO1C in sputum medium and sputum extracts. (a) Western blot analysis of lipid A, outer core, A-band and B-band from P. aeruginosa PAO1C cultured in (1) TSB, (2) ASM+, (3) ASM–, (4) sputum extract 5 and (5) sputum extract 6. The blot probed with the outer-core antibody 101 was subsequently re-probed with A-band antibody N1F10, thus showing the signals for the outer core plus A-band. (b) LPS profile of P. aeruginosa cultured in (1) TSB and (2) ASM+ visualized by silver staining.

 

Proteomics

The protein expression patterns of P. aeruginosa PAO1C in TSB, ASM+ and ASM– were compared by two-dimensional gel electrophoresis. Abundant expression of OprF was found only in ASM+ (Fig. 7).



View larger version (43K):
[in this window]
[in a new window]
 
Fig. 7. Two-dimensional gel electrophoresis patterns of proteins of P. aeruginosa PAO1C cultured in TSB, ASM+ and ASM–. Arrow, major outer-membrane protein OprF.

 


    DISCUSSION
 TOP
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
In this study a novel biofilm model, tight microcolony formation in artificial sputum medium, that mimics P. aeruginosa growth in the CF lung is presented. P. aeruginosa exhibited similar characteristics when grown in artificial sputum medium and in sputum extracts. In addition, PAO1C, a burn wound isolate, grown in artificial sputum medium displayed characteristics of isolates from the CF lung.

For some time P. aeruginosa has been the model organism for biofilm formation and its growth in microcolonies in the CF lung has been the paradigm of a chronic disease caused by biofilm-forming bacteria (Lam et al., 1980). Several biofilm models have been developed for P. aeruginosa over time, and most of them measured biofilm formation on a solid surface (Yoon et al., 2002). However, several studies have shown that P. aeruginosa grows in the CF lung in microcolonies attached predominantly to mucin (Baltimore et al., 1989; Lam et al., 1980; Worlitzsch et al., 2002). We were able to demonstrate that P. aeruginosa grows readily as microcolonies when grown in a medium that reflects the chemical environment in the CF lung. Such a special biofilm, in which cells adhere to each other but not to the surface, is unconventional but in agreement with the definition of Costerton et al. (1995) that biofilms are ‘matrix-enclosed bacterial populations adherent to each other and/or to surfaces or interfaces'.

Although the flagellum has been shown to have a role in biofilm formation, the fact that the majority of CF isolates are usually non-motile and do not express the flagellin protein (Mahenthiralingam et al., 1994) raises the question about the direct involvement of the flagellum in CF-associated P. aeruginosa biofilms. Since in the artificial sputum medium tight microcolonies were formed without the requirement of the flagellum, this evidence supports the non-motile attributes of isolates from CF sputum samples and further contradicts the necessity of the flagellum for biofilm formation (Yoon et al., 2002). However, this does not rule out the role of the flagellar cap protein FliD for mucin adhesion by P. aeruginosa (Arora et al., 1998).

Nevertheless, our model system showed similarities to previous models (O'Toole & Kolter, 1998; Yoon et al., 2002). Structural components such as the exopolysaccharide alginate, the type IV pili, LPS or rhamnolipids and the outer-membrane protein OprF are required for tight microcolony formation. In contrast to Mahenthiralingam et al. (1994), we rarely observed complete loss of twitching motility in isolates of a prevalent CF clone (unpublished data), which supports an in vivo role of type IV pili in microcolony formation. LPS and rhamnolipids have been shown to contribute to conventional biofilm formation (Beveridge et al., 1997; Davey et al., 2003). RmlA encodes the first enzyme in the biosynthesis of deoxythymidine-diphosphate (dTDP)-rhamnose, the precursor of L-rhamnose, a component of the core oligosaccharide of LPS and secreted rhamnolipids.

Changes in cell metabolism also appear to contribute to tight microcolony formation. SucC encodes the beta chain of succinyl-CoA synthetase, an enzyme of the Krebs cycle, which, in other systems, has been found to be required for biofilm formation (Solano et al., 2002) or be upregulated in biofilms (Beloin et al., 2004). We also demonstrated the contribution of the 3O-C12-HSL quorum sensing signalling pathway to tight microcolony formation and a similar production of signalling molecules in ASM+ and a sputum extract. It has been demonstrated that N-acyl homoserine-lactones are produced in vivo (Middleton et al., 2002).

The most intriguing finding was that almost all of the sputum components were required for tight microcolony formation, for example eukaryotic DNA. Recently, it was shown that bacterial DNA was required for biofilm formation (Whitchurch et al., 2002), but in sputum, eukaryotic DNA released by neutrophils is much more abundant. Inhalation of DNase I is an established therapy that has been shown to improve lung function and reduce pulmonary exacerbations in CF patients. Generally, the mechanism of DNase I therapeutics is the reduction of sputum viscosity, thereby facilitating expectoration (Gibson et al., 2003). However, reduced microcolony formation, which facilitates eradication of bacteria, might also contribute to improved health development after DNase I treatment.

Besides being required for attachment, mucin was found to be a major nutrient source, but lecithin was also required. Based on previous studies, the sputum of CF patients is a nutrient-rich environment (Barth & Pitt, 1996; Ohman & Chakrabarty, 1982); however, an abundance of nutrients does not necessarily cause rapid growth of the organisms. Indeed, a slow growth rate of P. aeruginosa was observed with and without amino acids.

The non-specific porin OprF was upregulated only in artificial sputum medium with amino acids. Thus, the presence of amino acids might be a signal for enhanced OprF expression. Alternatively, the effect of amino acids might only be indirect. Recently, it has been shown that OprF is highly expressed in anaerobic biofilms, where it is required for anaerobic respiration (Yoon et al., 2002). In our model, the formation of tight microcolonies might already provide an environment with a sufficiently low oxygen tension.

We are aware of the fact that the artificial sputum medium described here is not entirely representative of sputum in the lung because other biologically active components, which could also serve as nutrients, are present in the sputum, including lactoferrin, oligopeptides and other lipids besides lecithin (Ohman & Chakrabarty, 1982; Sahu & Lynn, 1978). Nonetheless, P. aeruginosa grown in artificial sputum medium and sputum extracts exhibited similar characteristics to patients’ isolates.

The sputum from each individual patient has a unique composition, which varies with the underlying CF phenotype and disease progression. Since the amino acid content correlates with disease severity (Thomas et al., 2000) and tight microcolony formation of P. aeruginosa (this study), we envisage the initiation of a vicious cycle in the patient whereby a more severe disease phenotype reduces the probability of its eradication from the lung. The isolation of mucoid colonies from CF patients indicates that P. aeruginosa has established itself as a persistent resident and this correlates with poor prognosis. We speculate that the emergence and establishment of the mucoid form might also be connected with changes in amino acid content of the sputum.

Clearly, the artificial sputum medium does not resemble the acute phase of the infection but the established colonization of P. aeruginosa. In this phase of the infection process, antibiotic resistance of P. aeruginosa is the problem of utmost clinical importance. However, clinical observations did not find a correlation between resistance of P. aeruginosa to tobramycin and effective treatment of patients (Smith et al., 2003). Using the artificial sputum medium antibiotic-resistance mechanisms of P. aeruginosa forming microcolonies can be systematically investigated.


    ACKNOWLEDGEMENTS
 TOP
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
We cordially thank Rita Getzlaff for the measurement of the amino acid concentrations. We thank Stephen Diggle, Andreas Kresse, Paul Williams, Reuben Ramphal, Judith Ries, Daniel J. Wozniak and Hongwei Yu who kindly provided sputum samples and strains.

S. D. D. was a member of the European Graduate College ‘Pseudomonas aeruginosa: Pathogenicity and Biotechnology’ funded by the German Research Foundation (DFG). This research was also supported by the Karolinska Institutet (`Elitforskartjänst’ to U. R.) and the Mukoviszidose e.V. J. S. L. currently holds a Canada Research Chair in Cystic Fibrosis and Microbial Glycobiology. Research in J. S. L.'s laboratory is supported by the Canadian Cystic Fibrosis Foundation.


    REFERENCES
 TOP
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 

  • Arora, S. K., Ritchings, B. W., Almira, E. C., Lory, S. & Ramphal, R. (1998). The Pseudomonas aeruginosa flagellar cap protein, FliD, is responsible for mucin adhesion. Infect Immun 66, 1000–1007.[Abstract/Free Full Text]

  • Baltimore, R. S., Christie, C. D. C. & Walker Smith, G. J. (1989). Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Am Rev Respir Dis 140, 1650–1661.[Medline]

  • Barth, A. L. & Pitt, T. L. (1996). The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa. J Med Microbiol 45, 110–119.[Abstract/Free Full Text]

  • Beloin, C., Valle, J., Latour-Lambert, P. & 8 other authors (2004). Global impact of mature biofilm lifestyle on Escherichia coli K-12 gene expression. Mol Microbiol 51, 659–674.[CrossRef][Medline]

  • Beveridge, T. J., Makin, S. A., Kadurugamuwa, J. L. & Li, Z. (1997). Interactions between biofilms and the environment. FEMS Microbiol Rev 20, 291–303.[CrossRef][Medline]

  • Boddicker, J. D., Ledeboer, N. A., Jagnow, J., Jones, B. D. & Clegg, S. (2002). Differential binding to and biofilm formation on, HEp-2 cells by Salmonella enterica serovar Typhimurium is dependent upon allelic variation in the fimH gene of the fim gene cluster. Mol Microbiol 45, 1255–1265.[CrossRef][Medline]

  • Christensen, B. B., Sternberg, C., Andersen, J. B., Palmer, R. J. Jr, Nielsen, A. T., Givskov, M. & Molin, S. (1999). Molecular tools for study of biofilm physiology. Methods Enzymol 310, 20–42.[Medline]

  • Costerton, J. W., Lewandowski, Z., Caldwell, D. E., Korber, D. R. & Lappin-Scott, H. M. (1995). Microbial biofilms. Annu Rev Microbiol 49, 711–745.[CrossRef][Medline]

  • Davey, M. E., Caiazza, N. C. & O'Toole, G. A. (2003). Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1. J Bacteriol 185, 1027–1036.[Abstract/Free Full Text]

  • de Kievit, T. R. & Lam, J. S. (1994). Monoclonal antibodies that distinguish inner core, outer core, and lipid A regions of Pseudomonas aeruginosa lipopolysaccharide. J Bacteriol 176, 7129–7139.[Abstract/Free Full Text]

  • Diggle, S. P., Winzer, K., Lazdunski, A., Williams, P. & Camara, M. (2002). Advancing the quorum in Pseudomonas aeruginosa: MvaT and the regulation of N-acylhomoserine lactone production and virulence gene expression. J Bacteriol 184, 2576–2586.[Abstract/Free Full Text]

  • Ernst, R. K., Yi, E. C., Guo, L., Lim, K. B., Burns, J. L., Hackett, M. & Miller, S. I. (1999). Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 286, 1561–1565.[Abstract/Free Full Text]

  • Feldman, M., Bryan, R., Rajan, S., Scheffler, L., Brunnert, S., Tang, H. & Prince, A. (1998). Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect Immun 66, 43–51.[Abstract/Free Full Text]

  • Ghani, M. & Soothill, J. S. (1997). Ceftazidime, gentamicin, and rifampicin, in combination, kill biofilms of mucoid Pseudomonas aeruginosa. Can J Microbiol 43, 999–1004.[Medline]

  • Gibson, R. L., Burns, J. L. & Ramsey, B. W. (2003). Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168, 918–951.[Abstract/Free Full Text]

  • Gorg, A., Obermaier, C., Boguth, G., Harder, A., Scheibe, B., Wildgruber, R. & Weiss, W. (2000). The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21, 1037–1053.[CrossRef][Medline]

  • Govan, J. R. (1975). Mucoid strains of Pseudomonas aeruginosa: the influence of culture medium on the stability of mucus production. J Med Microbiol 8, 513–522.[Abstract/Free Full Text]

  • Hancock, R. E., Mutharia, L. M., Chan, L., Darveau, R. P., Speert, D. P. & Pier, G. B. (1983). Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect Immun 42, 170–177.[Abstract/Free Full Text]

  • Head, N. E. & Yu, H. (2004). Cross-sectional analysis of clinical and environmental isolates of Pseudomonas aeruginosa: biofilm formation, virulence, and genome diversity. Infect Immun 72, 133–144.[Abstract/Free Full Text]

  • Hitchcock, P. J. & Brown, T. M. (1983). Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J Bacteriol 154, 269–277.[Abstract/Free Full Text]

  • Kilbourn, J. P. (1978). Bacterial content and ionic composition of sputum in cystic fibrosis. Lancet 1, 334. 334.[Medline]

  • Kresse, A. U., Dinesh, S. D., Larbig, K. & Römling, U. (2003). Impact of large chromosomal inversions on the adaptation and evolution of Pseudomonas aeruginosa chronically colonizing cystic fibrosis lungs. Mol Microbiol 47, 145–158.[CrossRef][Medline]

  • Lam, J., Chan, R., Lam, K. & Costerton, J. W. (1980). Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun 28, 546–556.[Abstract/Free Full Text]

  • Lesse, A. J., Campagnari, A. A., Bittner, W. E. & Apicella, M. A. (1990). Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Immunol Methods 126, 109–117.[CrossRef][Medline]

  • Lünsdorf, H., Strompl, C., Osborn, A. M., Bennasar, A., Moore, E. R., Abraham, W. R. & Timmis, K. N. (2001). Approach to analyze interactions of microorganisms, hydrophobic substrates, and soil colloids leading to formation of composite biofilms, and to study initial events in microbiogeological processes. Methods Enzymol 336, 317–331.[Medline]

  • Mahenthiralingam, E., Campbell, M. E. & Speert, D. P. (1994). Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun 62, 596–605.[Abstract/Free Full Text]

  • Middleton, B., Rodgers, H. C., Camara, M., Knox, A. J., Williams, P. & Hardman, A. (2002). Direct detection of N-acylhomoserine lactones in cystic fibrosis sputum. FEMS Microbiol Lett 207, 1–7.[CrossRef][Medline]

  • Ohman, D. E. & Chakrabarty, A. M. (1982). Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin. Infect Immun 37, 662–669.[Abstract/Free Full Text]

  • O'Toole, G. A. & Kolter, R. (1998). Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 30, 295–304.[CrossRef][Medline]

  • Ramsey, B. W., Pepe, M. S., Quan, J. M. & 9 other authors (1999). Intermittent administration of inhaled tobramycin in patients with cystic fibrosis.Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med 340, 23–30.[Abstract/Free Full Text]

  • Römling, U., Fiedler, B., Bosshammer, J., Grothues, D., Greipel, J., von der Hardt, H. & Tummler, B. (1994a). Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J Infect Dis 170, 1616–1621.[Medline]

  • Römling, U., Wingender, J., Muller, H. & Tummler, B. (1994b). A major Pseudomonas aeruginosa clone common to patients and aquatic habitats. Appl Environ Microbiol 60, 1734–1738.[Abstract/Free Full Text]

  • Römling, U., Schmidt, K. D. & Tümmler, B. (1997). Large genome rearrangements discovered by the detailed analysis of 21 Pseudomonas aeruginosa clone C isolates found in environment and disease habitats. J Mol Biol 271, 386–404.[CrossRef][Medline]

  • Römling, U., Sierralta, W. D., Eriksson, K. & Normark, S. (1998). Multicellular and aggregative behaviour of Salmonella typhimurium strains is controlled by mutations in the agfD promoter. Mol Microbiol 28, 249–264.[CrossRef][Medline]

  • Sahu, S. & Lynn, W. S. (1978). Lipid composition of sputum from patients with asthma and patients with cystic fibrosis. Inflammation 3, 27–36.[CrossRef][Medline]

  • Singh, P. K., Schaefer, A. L., Parsek, M. R., Moninger, T. O., Welsh, M. J. & Greenberg, E. P. (2000). Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407, 762–764.[CrossRef][Medline]

  • Smith, A. L., Redding, G., Doershuk, C. & 14 other authors (1988). Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis. J Pediatr 112, 547–554.[CrossRef][Medline]

  • Smith, A. L., Fiel, S. B., Mayer-Hamblett, N., Ramsey, B. & Burns, J. L. (2003). Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis. Chest 123, 1495–1502.[Abstract/Free Full Text]

  • Solano, C., Garcia, B., Valle, J., Berasain, C., Ghigo, J. M., Gamazo, C. & Lasa, I. (2002). Genetic analysis of Salmonella enteritidis biofilm formation: critical role of cellulose. Mol Microbiol 43, 793–808.[CrossRef][Medline]

  • Thomas, S. R., Ray, A., Hodson, M. E. & Pitt, T. L. (2000). Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax 55, 795–797.[Abstract/Free Full Text]

  • Tsai, C. M. & Frasch, C. E. (1982). A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem 119, 115–119.[CrossRef][Medline]

  • Wang, J., Lory, S., Ramphal, R. & Jin, S. (1996). Isolation and characterization of Pseudomonas aeruginosa genes inducible by respiratory mucus derived from cystic fibrosis patients. Mol Microbiol 22, 1005–1012.[CrossRef][Medline]

  • Whitchurch, C. B., Tolker-Nielsen, T., Ragas, P. C. & Mattick, J. S. (2002). Extracellular DNA required for bacterial biofilm formation. Science 295, 1487. 1487.[Free Full Text]

  • Woolwine, S. C. & Wozniak, D. J. (1999). Identification of an Escherichia coli pepA homolog and its involvement in suppression of the algB phenotype in mucoid Pseudomonas aeruginosa. J Bacteriol 181, 107–116.[Abstract/Free Full Text]

  • Worlitzsch, D., Tarran, R., Ulrich, M. & 12 other authors (2002). Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109, 317–325.[CrossRef][Medline]

  • Wozniak, D. J., Wyckoff, T. J., Starkey, M., Keyser, R., Azadi, P., O'Toole, G. A. & Parsek, M. R. (2003). Alginate is not a significant component of the extracellular polysaccharide matrix of PA14 and PAO1 Pseudomonas aeruginosa biofilms. Proc Natl Acad Sci U S A 100, 7907–7912.[Abstract/Free Full Text]

  • Wu, H., Song, Z., Givskov, M., Doring, G., Worlitzsch, D., Mathee, K., Rygaard, J. & Hoiby, N. (2001). Pseudomonas aeruginosa mutations in lasI and rhlI quorum sensing systems result in milder chronic lung infection. Microbiology 147, 1105–1113.[Abstract/Free Full Text]

  • Yakimov, M. M., Golyshin, P. N., Lang, S., Moore, E. R., Abraham, W. R., Lünsdorf, H. & Timmis, K. N. (1998). Alcanivorax borkumensis gen.nov., sp. nov., a new, hydrocarbon-degrading and surfactant-producing marine bacterium. Int J Syst Bacteriol 48, 339–348.[Abstract/Free Full Text]

  • Yoon, S. S., Hennigan, R. F., Hilliard, G. M. & 17 other authors (2002). Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev Cell 3, 593–603.[CrossRef][Medline]




    This article has been cited by other articles:


    Home page
    Microbiol. Mol. Biol. Rev.Home page
    E. Karatan and P. Watnick
    Signals, Regulatory Networks, and Materials That Build and Break Bacterial Biofilms
    Microbiol. Mol. Biol. Rev., June 1, 2009; 73(2): 310 - 347.
    [Abstract] [Full Text] [PDF]


    Home page
    Antimicrob. Agents Chemother.Home page
    L. Vettoretti, P. Plesiat, C. Muller, F. El Garch, G. Phan, I. Attree, A. Ducruix, and C. Llanes
    Efflux Unbalance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
    Antimicrob. Agents Chemother., May 1, 2009; 53(5): 1987 - 1997.
    [Abstract] [Full Text] [PDF]


    Home page
    J Med MicrobiolHome page
    Q. M. Parks, R. L. Young, K. R. Poch, K. C. Malcolm, M. L. Vasil, and J. A. Nick
    Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy
    J. Med. Microbiol., April 1, 2009; 58(4): 492 - 502.
    [Abstract] [Full Text] [PDF]


    Home page
    J. Bacteriol.Home page
    K. L. Palmer, L. M. Aye, and M. Whiteley
    Nutritional Cues Control Pseudomonas aeruginosa Multicellular Behavior in Cystic Fibrosis Sputum
    J. Bacteriol., November 15, 2007; 189(22): 8079 - 8087.
    [Abstract] [Full Text] [PDF]


    Home page
    J. Bacteriol.Home page
    T. Tralau, S. Vuilleumier, C. Thibault, B. J. Campbell, C. A. Hart, and M. A. Kertesz
    Transcriptomic Analysis of the Sulfate Starvation Response of Pseudomonas aeruginosa
    J. Bacteriol., October 1, 2007; 189(19): 6743 - 6750.
    [Abstract] [Full Text] [PDF]


    Home page
    J. Bacteriol.Home page
    Y. Fouhy, K. Scanlon, K. Schouest, C. Spillane, L. Crossman, M. B. Avison, R. P. Ryan, and J. M. Dow
    Diffusible Signal Factor-Dependent Cell-Cell Signaling and Virulence in the Nosocomial Pathogen Stenotrophomonas maltophilia
    J. Bacteriol., July 1, 2007; 189(13): 4964 - 4968.
    [Abstract] [Full Text] [PDF]


    Home page
    J. Bacteriol.Home page
    J. A. Jurcisek and L. O. Bakaletz
    Biofilms Formed by Nontypeable Haemophilus influenzae In Vivo Contain both Double-Stranded DNA and Type IV Pilin Protein
    J. Bacteriol., May 15, 2007; 189(10): 3868 - 3875.
    [Abstract] [Full Text] [PDF]


    Home page
    MicrobiologyHome page
    L. Yang, K. B. Barken, M. E. Skindersoe, A. B. Christensen, M. Givskov, and T. Tolker-Nielsen
    Effects of iron on DNA release and biofilm development by Pseudomonas aeruginosa
    Microbiology, May 1, 2007; 153(5): 1318 - 1328.
    [Abstract] [Full Text] [PDF]


    Home page
    Proc. Natl. Acad. Sci. USAHome page
    H. Matsui, V. E. Wagner, D. B. Hill, U. E. Schwab, T. D. Rogers, B. Button, R. M. Taylor II, R. Superfine, M. Rubinstein, B. H. Iglewski, et al.
    A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms
    PNAS, November 28, 2006; 103(48): 18131 - 18136.
    [Abstract] [Full Text] [PDF]


    Home page
    The Annals of PharmacotherapyHome page
    J. A Bosso, P. D Mauldin, and L. L Steed
    Consequences of Combining Cystic Fibrosis- and Non-Cystic Fibrosis-Derived Pseudomonas aeruginosa Antibiotic Susceptibility Results in Hospital Antibiograms
    Ann. Pharmacother., November 1, 2006; 40(11): 1946 - 1949.
    [Abstract] [Full Text] [PDF]


    Home page
    Antimicrob. Agents Chemother.Home page
    C. Mugabe, M. Halwani, A. O. Azghani, R. M. Lafrenie, and A. Omri
    Mechanism of Enhanced Activity of Liposome-Entrapped Aminoglycosides against Resistant Strains of Pseudomonas aeruginosa.
    Antimicrob. Agents Chemother., June 1, 2006; 50(6): 2016 - 2022.
    [Abstract] [Full Text] [PDF]


    Home page
    MicrobiologyHome page
    F. Diab, T. Bernard, A. Bazire, D. Haras, C. Blanco, and M. Jebbar
    Succinate-mediated catabolite repression control on the production of glycine betaine catabolic enzymes in Pseudomonas aeruginosa PAO1 under low and elevated salinities.
    Microbiology, May 1, 2006; 152(Pt 5): 1395 - 1406.
    [Abstract] [Full Text] [PDF]


    This Article
    Right arrow Abstract Freely available
    Right arrow Full Text (PDF)
    Right arrow Alert me when this article is cited
    Right arrow Alert me if a correction is posted
    Right arrow Citation Map
    Services
    Right arrow Email this article to a friend
    Right arrow Similar articles in this journal
    Right arrow Similar articles in PubMed
    Right arrow Alert me to new issues of the journal
    Right arrow Download to citation manager
    Right arrow reprints & permissions
    Citing Articles
    Right arrow Citing Articles via HighWire
    Right arrow Citing Articles via CrossRef
    Right arrow Citing Articles via Google Scholar
    Google Scholar
    Right arrow Articles by Sriramulu, D. D
    Right arrow Articles by Römling, U.
    Right arrow Search for Related Content
    PubMed
    Right arrow PubMed Citation
    Right arrow Articles by Sriramulu, D. D
    Right arrow Articles by Römling, U.
    Agricola
    Right arrow Articles by Sriramulu, D. D
    Right arrow Articles by Römling, U.


    HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
    INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS